drugset / Trial / NCT03400475

Use of Topical Subgingival Application of Simvastatin Gel in the Treatment of Peri-Implant Mucositis

NCT03400475

RandomizedParallel-groupTriple-blindTreatment

Summary

This study seeks to test the recently discovered anti-inflammatory action of statins on inflamed mucosa surrounding dental implants. Hypothesis: The application of 1.2% simvastatin gel will decrease peri-implant inflammation. The pilot study will involve 44 subjects divided into a test and control group. The test group shall receive topical simvastatin gel administered around the implant with a blunt tipped needle. The control group will receive a placebo. Inflammatory state shall be determined at baseline as well as follow up visits at 24 hours, 1 week, and 1 month by clinical indices of inflammation as well as biochemical markers of inflammation gathered from around the implants.

Timeline

Start
2015-04-23
Primary completion
2016-10-24
Completion
2016-10-24

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Simvastatin Small molecule 1.2 % Topical

Indications